Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Gbp Regulatory News (CVCG)

Share Price Information for Cvc Ig Gbp (CVCG)

Share Price is delayed by 15 minutes
Get Live Data
116.00    0.00 (0.00%)
Bid:
115.50
Ask:
116.50
Spread: 1.00 (0.866%)
Market Cap: £321.95m
CVCG Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Gbp Share Chart

Share Price Movement Update

17 Mar 2026 15:42

RNS Number : 0171X
CVC Income & Growth Limited
17 March 2026
 

17 March 2026

 

CVC Income & Growth Limited

(the Company)

 

Share Price Movement Update

 

The Board of the Company notes the recent share price movements in the Sterling and Euro share classes since the beginning of 2026 and provides the following update.

The Company's Sterling and Euro share price has fallen by more than 8% (as at close of trading on 16 March 2026). This decrease in share price is significantly more than the UBS European Leveraged Loan index which has fallen by 0.81% Year to Date (YTD) and Bloomberg European Leveraged Loan index which has fallen 0.98% YTD. The Board and the Investment Vehicle Manager consider it is reasonable to believe that the underlying portfolio's performance should broadly track the indices.

 

Publicly traded corporate credit versus private credit

The Company provides exposure primarily to publicly traded corporate credit, including syndicated loans and bonds. These assets differ from private credit investments in that they are actively traded in secondary markets and priced daily, rather than typically being priced quarterly which is the case for private credit.

Circa 98% of the loans and bonds within the underlying portfolio are priced daily based on traded broker marks. The Company's shares trade intraday on the London Stock Exchange, providing shareholders with daily secondary market liquidity.

 

Interest rate environment

Recent geopolitical developments and energy market volatility have contributed to increased uncertainty regarding the outlook for inflation and the path of interest rates during 2026. At the beginning of the year, the market had anticipated a series of interest rate reductions from the Bank of England, while the European Central Bank was expected to hold interest rates flat. However, renewed inflationary pressures, driven by energy markets, renewed supply chain issues and geopolitical developments, have contributed to a reassessment of the trajectory for interest rates in both geographies.

The Company's strategy focuses on floating-rate credit instruments, primarily senior secured loans. As a result, the income generated by the underlying portfolio is linked to prevailing base rates. In an environment where the pace of rate reductions is slower than previously anticipated, the portfolio's floating-rate characteristics may support the level of income generated by the underlying assets, subject to broader market conditions and portfolio performance.

 

Exposure to the software sector

Recent media coverage has highlighted concerns around sector concentration in software lending, which in some credit portfolios can represent a significant proportion of assets.

The Company has an exposure of circa 3% to software companies.

The Company's Investment Vehicle Manager notes: "The outlook for 2026 was fairly benign at the start of the year, which was reflected in credit spreads. Since then, markets have repriced software risk in both public equity and public credit markets given the fast-paced developments we've seen in AI. After the recent developments in the Middle East, markets have also started to price in higher for longer oil prices which could result in a slowdown in growth, but also higher inflation, potential supply chain issues and a reduction in consumer confidence. At this point, it's impossible to say where the conflict is heading. The portfolio continues to generate income in line with expectations, but the marks on the underlying assets move on a daily basis reflecting sentiment around the conflict and global growth. Both public equity and credit markets have repriced since the start of the year, resulting in a small negative NAV performance YTD. This shows that public credit markets are functioning."

 

--- END ---

 

Enquiries:

Cadarn Capital

Email: info@cadarncapital.com

 

BNP Paribas S.A. Jersey Branch

Email: cvccpeolcosec@bnpparibas.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGMFKNGGVZM
Date   Source Headline
4th Jun 20264:55 pmRNSIssue of Equity
1st Jun 202612:05 pmRNSNet Asset Value Weekly to 22 May 2026
1st Jun 202610:11 amRNSTotal Voting Rights
29th May 20265:20 pmRNSPUBLICATION OF MONTHLY REPORT
27th May 20264:12 pmRNSIssue of Equity
26th May 20264:51 pmRNSNet Asset Value Month End 30 Apr 2026
21st May 202610:15 amRNSNet Asset Value Weekly to 15 May 2026
15th May 20262:44 pmRNSTotal Voting Rights
14th May 20266:00 pmRNSNet Asset Value Weekly to 08 May 2026
12th May 20262:55 pmRNSNet Asset Value Weekly to 01 May 2026
12th May 20262:51 pmRNSIssue of Equity
7th May 202612:42 pmRNSMARCH 2026 TENDER - PURCHASE OF SHARES
1st May 202610:15 amRNSNet Asset Value Weekly to 24 Apr 2026
1st May 20269:31 amRNSTotal Voting Rights
29th Apr 20263:16 pmRNSPUBLICATION OF MONTHLY REPORT
28th Apr 20262:24 pmRNSDividend Declaration
28th Apr 20261:05 pmRNSResults of 2026 Annual General Meeting
27th Apr 20265:03 pmRNSMarch 2026 Tender Price
27th Apr 20263:44 pmRNSNet Asset Value Month End 31 Mar 2026
24th Apr 20261:25 pmRNSNet Asset Value Weekly to 17 Apr 2026
21st Apr 20264:15 pmRNSMarch 2026 Tender Price
21st Apr 20263:52 pmRNSIssue of Equity
16th Apr 20265:25 pmRNSNet Asset Value Weekly to 10 Apr 2026
10th Apr 20265:40 pmRNSNet Asset Value Weekly to 02 Apr 2026
10th Apr 20261:57 pmRNSNotice of 2026 Annual General Meeting
7th Apr 202610:40 amRNSNet Asset Value Weekly to 27 Mar 2026
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 202612:20 pmRNSNet Asset Value Weekly to 20 Mar 2026
25th Mar 202610:59 amRNSPublication of Monthly Report
24th Mar 20267:00 amRNS2025 Annual Report and Financial Statements
20th Mar 20264:01 pmRNSNet Asset Value Month End 27 Feb 2026
19th Mar 20266:00 pmRNSNet Asset Value Weekly to 13 Mar 2026
17th Mar 20263:42 pmRNSShare Price Movement Update
6th Mar 20264:10 pmRNSNet Asset Value Weekly to 27 Feb 2026
4th Mar 20262:32 pmRNSPUBLICATION OF MONTHLY REPORT
3rd Mar 202611:10 amRNSNet Asset Value Weekly to 20 Feb 2026
2nd Mar 202612:27 pmRNSNet Asset Value Month End 30 Jan 2026
2nd Mar 202610:21 amRNSTotal Voting Rights
26th Feb 20265:13 pmRNSIssue of Equity
20th Feb 20263:25 pmRNSNet Asset Value Weekly to 13 Feb 2026
19th Feb 20263:27 pmRNSIssue of Equity
13th Feb 20266:10 pmRNSNet Asset Value Weekly to 06 Feb 2026
13th Feb 20263:27 pmRNSResult of Tender Offer
12th Feb 20263:48 pmRNSIssue of Equity
6th Feb 202611:40 amRNSNet Asset Value Weekly to 30 Jan 2026
5th Feb 20264:51 pmRNSIssue of Equity
2nd Feb 20265:45 pmRNSNet Asset Value Weekly to 23 Jan 2026
2nd Feb 20264:16 pmRNSDirector/PDMR Shareholding
2nd Feb 202610:39 amRNSTotal Voting Rights
28th Jan 20263:48 pmRNSPublication of Monthly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.